schliessen

Filtern

 

Bibliotheken

An Evaluation Synthesis of US AIDS Drug Assistance Program Policy

US Congress passed the CARE Act in 1990 in response to a dramatically growing need for resources to combat the AIDS epidemic. One of the programs contained in the Act was the AIDS Drug Assistance Program (ADAP), a feder ally-funded but state-maintained and managed program primarily concerned with pr... Full description

Journal Title: World Journal of AIDS 2013, Vol.03(02), pp.85-91
Main Author: Horneffer, Michael A.
Other Authors: Yang, Y. Tony
Format: Electronic Article Electronic Article
Language:
Subjects:
ID: ISSN: 2160-8814 ; E-ISSN: 2160-8822 ; DOI: http://dx.doi.org/10.4236/wja.2013.32012
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: crossref10.4236/wja.2013.32012
title: An Evaluation Synthesis of US AIDS Drug Assistance Program Policy
format: Article
creator:
  • Horneffer, Michael A.
  • Yang, Y. Tony
subjects:
  • Medicine
ispartof: World Journal of AIDS, 2013, Vol.03(02), pp.85-91
description: US Congress passed the CARE Act in 1990 in response to a dramatically growing need for resources to combat the AIDS epidemic. One of the programs contained in the Act was the AIDS Drug Assistance Program (ADAP), a feder ally-funded but state-maintained and managed program primarily concerned with providing medication for low-income HIV/AIDS patients. While ADAP programs across the country reached one-third of all patients in 2007, these programs are now in budgetary danger due to the economic recession, state budgetary constraints, the rising cost of healthcare generally, and longer life expectancies associated with current highly active antiretroviral therapy (HAART). This paper first evaluates the current state of ADAP, its strengths and weaknesses, and examines its sustainability in the short term if short-term measures are taken. Concluding that such measures would not lead to long-term sustainability, this paper then argues for a long-term solution to ADAP’s current problems, namely a national, centralized ADAP standard for budgetary and administrative matters. Such a program would increase the long-term sustainability and effectiveness of current ADAP programs by employing more efficient, standard policies and allowing larger, wholesale purchases of costly HAART medications. Moreover, a national policy would address the disparity that currently exists in ADAP programs today with regard to both minorities and those on the waiting lists for treatment. The institution of a national ADAP program would certainly face many political hurdles. Consequently, this paper also looks to a recent political dispute, the enactment of the Affordable Care Act (ACA), for guidance. Using the passage of the ACA as an example could light the path for passage of a national ADAP standard. Ultimately, this would lead to a more effective and sus tainable program for HIV/AIDS patients in the United States.
language:
source:
identifier: ISSN: 2160-8814 ; E-ISSN: 2160-8822 ; DOI: http://dx.doi.org/10.4236/wja.2013.32012
fulltext: fulltext
issn:
  • 21608814
  • 2160-8814
  • 21608822
  • 2160-8822
url: Link


@attributes
ID214559598
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10.4236/wja.2013.32012
sourceidcrossref
recordidTN_crossref10.4236/wja.2013.32012
sourceformatXML
sourcesystemPC
display
typearticle
titleAn Evaluation Synthesis of US AIDS Drug Assistance Program Policy
creatorHorneffer, Michael A. ; Yang, Y. Tony
ispartofWorld Journal of AIDS, 2013, Vol.03(02), pp.85-91
identifier
source
lds412013
subjectMedicine;
descriptionUS Congress passed the CARE Act in 1990 in response to a dramatically growing need for resources to combat the AIDS epidemic. One of the programs contained in the Act was the AIDS Drug Assistance Program (ADAP), a feder ally-funded but state-maintained and managed program primarily concerned with providing medication for low-income HIV/AIDS patients. While ADAP programs across the country reached one-third of all patients in 2007, these programs are now in budgetary danger due to the economic recession, state budgetary constraints, the rising cost of healthcare generally, and longer life expectancies associated with current highly active antiretroviral therapy (HAART). This paper first evaluates the current state of ADAP, its strengths and weaknesses, and examines its sustainability in the short term if short-term measures are taken. Concluding that such measures would not lead to long-term sustainability, this paper then argues for a long-term solution to ADAP’s current problems, namely a national, centralized ADAP standard for budgetary and administrative matters. Such a program would increase the long-term sustainability and effectiveness of current ADAP programs by employing more efficient, standard policies and allowing larger, wholesale purchases of costly HAART medications. Moreover, a national policy would address the disparity that currently exists in ADAP programs today with regard to both minorities and those on the waiting lists for treatment. The institution of a national ADAP program would certainly face many political hurdles. Consequently, this paper also looks to a recent political dispute, the enactment of the Affordable Care Act (ACA), for guidance. Using the passage of the ACA as an example could light the path for passage of a national ADAP standard. Ultimately, this would lead to a more effective and sus tainable program for HIV/AIDS patients in the United States.
version2
lds50peer_reviewed
links
openurl$$Topenurl_article
thumbnail
0$$TPCamazon_thumb
1$$TPCgoogle_thumb
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutCrossref.html$$EView_CrossRef_copyright_notice
search
creatorcontrib
0Horneffer, Michael A.
1Yang, Y. Tony
titleAn Evaluation Synthesis of US AIDS Drug Assistance Program Policy
general
010.4236/wja.2013.32012
1CrossRef
sourceidcrossref
recordidcrossref10.4236/wja.2013.32012
issn
021608814
12160-8814
221608822
32160-8822
rsrctypearticle
addtitle
0World Journal of AIDS
1WJA
searchscope
0crossref_rest
1CrossRef
2Crossref
3crossref
scope
0crossref_rest
1CrossRef
2Crossref
3crossref
lsr402013
lsr412013
lsr432013
lsr452013
tmp012
tmp022
creationdate2013
startdate20130101
enddate20131231
citationpf 85 pt 91 vol 03 issue 02
lsr30VSR-Enriched:[subject, description]
sort
titleAn Evaluation Synthesis of US AIDS Drug Assistance Program Policy
authorHorneffer, Michael A. ; Yang, Y. Tony
creationdate20130000
lso0120130000
facets
frbrgroupid7986004490973571445
frbrtype5
creationdate2013
prefilterarticles
rsrctypearticles
creatorcontrib
0Horneffer, Michael A.
1Yang, Y. Tony
jtitleWorld Journal of AIDS
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Horneffer
1Yang
aufirst
0Michael A.
1Y. Tony
au
0Horneffer, Michael A.
1Yang, Y. Tony
atitleAn Evaluation Synthesis of US AIDS Drug Assistance Program Policy
jtitleWorld Journal of AIDS
stitleWJA
date2013
risdate2013
adddate2013
volume03
issue02
spage85
epage91
pages85-91
issn2160-8814
eissn2160-8822
formatjournal
genrearticle
ristypeJOUR
doi10.4236/wja.2013.32012
lad012
citing
0$$t=2$$K3=10.1097/01.mlr.0000228021.89490.2a
1$$t=2$$K3=10.1086/341903
2$$t=2$$K3=10.1007/s10754-007-9012-0
3$$t=2$$K3=10.1086/508657